Skip to content

Drug interactions

Pasireotide + Telavancin

Severity: Moderate

Pasireotide and Telavancin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong the QT interval and cause bradycardia, and telavancin may add to QTc lengthening. The combination can increase the risk of torsades de pointes, especially with hypokalemia or hypomagnesemia.

What this interaction means in plain words

Pasireotide and Telavancin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pasireotide belongs to Endocrine; Telavancin belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation, with pasireotide-related bradycardia contributing.

What to do

Check a baseline ECG and correct potassium and magnesium before combining. Monitor the QTc and heart rate during therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pasireotide and Telavancin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pasireotide with Telavancin?

MediHelp rates the interaction as moderate. Pasireotide and Telavancin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can prolong the QT interval and cause bradycardia, and telavancin may add to QTc lengthening. The combination can increase the risk of torsades de pointes, especially with hypokalemia or hypomagnesemia.

How serious is the interaction between Pasireotide and Telavancin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check a baseline ECG and correct potassium and magnesium before combining. Monitor the QTc and heart rate during therapy.

What other medicines interact with Telavancin?

MediHelp also lists interactions of Telavancin with, for example, Thioridazine, Adagrasib, Amiodarone. The full list is on the Telavancin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in